Correct Answer: C. The fall in 2,3 DBG is less
The critical difference between citrate-phosphate-dextrose (CPD) and acid-citrate-dextrose (ACD) lies in their phosphate content and its effect on 2,3-diphosphoglycerate (2,3-DPG) preservation. During blood storage, glycolysis depletes ATP and 2,3-DPG levels progressively decline, causing a rightward shift of the oxygen-hemoglobin dissociation curve and reduced oxygen delivery to tissues—a particular concern in hypoxic patients who depend on efficient oxygen unloading. CPD contains phosphate buffer that better maintains intracellular pH and ATP levels, thereby slowing the rate of 2,3-DPG degradation. ACD, being more acidic (pH 4.5 vs CPD's 5.5), accelerates glycolytic enzyme inactivation and 2,3-DPG breakdown. In hypoxic patients, preserved 2,3-DPG is essential: it shifts the dissociation curve rightward, promoting oxygen release at lower partial pressures. CPD's superior preservation of 2,3-DPG (typically 50–70% retention vs 20–30% with ACD after 21 days) makes it the preferred storage medium for patients with compromised oxygen delivery. This is why Indian blood banks preferentially use CPD for routine transfusions, especially in critical care settings.
Why the other options are wrong
A. It has less P50 — This is incorrect and represents a fundamental misunderstanding of P50 physiology. P50 is the PO₂ at which hemoglobin is 50% saturated—a property of hemoglobin itself, not the storage medium. Neither CPD nor ACD changes hemoglobin's intrinsic P50. What matters is 2,3-DPG concentration, which shifts the curve and changes the effective P50 in vivo. A lower P50 would mean tighter oxygen binding—the opposite of what hypoxic patients need. This is an NBE trap exploiting confusion between P50 and 2,3-DPG effects. B. It is less acidic — While CPD is indeed less acidic than ACD, this is not the primary reason for preferring it in hypoxic patients. The acidity difference is a mechanism, not the clinical endpoint. The question specifically asks about suitability for hypoxic patients, where oxygen delivery is the critical issue. Reduced acidity helps preserve 2,3-DPG, but stating 'less acidic' misses the pathophysiological target. An examiner testing deeper knowledge would reject this as incomplete reasoning, even though it's partially true. D. None of the above — This is a distractor for students uncertain about 2,3-DPG physiology or those who overthink the question. Since option C (the fall in 2,3-DPG is less) is scientifically accurate and directly addresses the clinical need in hypoxic patients, 'None of the above' is definitively wrong. This trap catches students who lack confidence in their understanding of oxygen-hemoglobin dynamics and blood storage biochemistry.
High-Yield Facts
- 2,3-DPG preservation is the key discriminator between CPD and ACD; CPD retains 50–70% of 2,3-DPG after 21 days vs. 20–30% with ACD.
- CPD has phosphate buffer that maintains pH ~5.5 and slows glycolytic enzyme inactivation, preserving ATP and 2,3-DPG.
- 2,3-DPG shifts the oxygen-hemoglobin curve rightward, reducing P50 and promoting oxygen release at lower PO₂—critical in hypoxic states.
- ACD is more acidic (pH ~4.5), accelerating 2,3-DPG breakdown and causing a leftward curve shift (increased oxygen affinity, reduced delivery).
- Hypoxic patients depend on rightward curve shift to extract oxygen at low ambient PO₂; stored blood with depleted 2,3-DPG worsens tissue oxygenation.
Mnemonics
CPD > ACD for Hypoxia CPD = Conserves 2,3-DPG (Phosphate buffer); ACD = Accelerates 2,3-DPG loss (Acidic). In hypoxia, you need rightward shift → need 2,3-DPG → use CPD. 2,3-DPG Effect Memory Hook High 2,3-DPG = curve shifts RIGHT = oxygen RELEASED easily (good for hypoxia). Low 2,3-DPG (as in stored ACD blood) = curve shifts LEFT = oxygen HELD tight (bad for hypoxia).
NBE Trap
NBE pairs 'less acidic' (option B) with CPD to trap students who confuse the mechanism (pH preservation) with the clinical endpoint (2,3-DPG preservation). Students may select B thinking acidity is the answer, missing that the question specifically asks about suitability in hypoxic patients, where oxygen delivery—not pH per se—is the discriminator.
Clinical Pearl
In Indian ICUs managing septic shock or hemorrhagic shock, transfusing ACD-stored blood to a hypoxic patient worsens tissue oxygenation because the blood's 2,3-DPG is depleted, causing the hemoglobin to grip oxygen tightly and release it poorly at the tissue level. CPD-stored blood, with better 2,3-DPG retention, actually improves oxygen unloading in these critical scenarios—a bedside difference that can influence patient outcomes.
_Reference: Robbins & Cotran Pathology Ch. 13 (Blood Banking); Harrison's Principles of Internal Medicine Ch. 107 (Transfusion Medicine); KD Tripathi Pharmacology Ch. 18 (Blood and Blood Products)_